Syndax Pharmaceuticals (SNDX) Tops Q1 EPS by 17c

Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q1 EPS of ($0.79), $0.17 better than the analyst estimate of ($0.96).

For earnings history and earnings-related data on Syndax Pharmaceuticals (SNDX) click here.

You May Also Be Interested In

• Delta Air Lines stock climbs on earnings beat and strong guidance
• Goldman says rotation driven by positioning, not fundamentals
• Ategrity reports record Q2 results, names new CFO